COVID vaccination

Adar Poonawalla, CEO, SII also pitched for a global pact for vaccine utilisation

The Centre announced that the precaution dose of COVID vaccines will be available to everyone aged above 18 years at the private…

International data available on booster doses of AstraZeneca and Covishield suggests a three-to four-fold increase in antibody…

CDSCO has granted permission to CMC, Vellore, to conduct phase-IV study with Covishield and Covaxin to compare immunogenicity of…

Hetero is the first biopharma company in India to receive Manufacturing and Marketing (M&M) approval for the product…

Two doses of Biological E’s intramuscular vaccine Corbevax would be administered to the beneficiaries in the 12-14 years age group…

The Drugs Controller General Of India (DCGI) has already approved Covovax for restricted use in emergency situations in adults on…

Addressing a press conference, V K Paul, member (health), NITI Aayog, said studies are going on regarding the mixing and matching…

Over 90 per cent of Indians believe that vaccine’s role is vital to fight against COVID-19 whereas over 85 per cent believes that…

He was speaking at a virtual roundtable on “Vaccine for All” during which eminent participants including Bill Gates discussed how…